Loxetine 20 mg (Tablet (Delayed Release))
Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)
Strip Price: ৳ 80.00
Medicine Details
Category | Details |
---|---|
Generic | Duloxetine hydrochloride |
Company | Aci limited |
Also available as |
Product Title
- Loxetine Serotonin and Norepinephrine Reuptake Inhibitor (SNRI)
Category
- Medication
Indications
- Major Depressive Disorder (MDD)
- Generalized Anxiety Disorder (GAD)
- Diabetic Peripheral Neuropathic Pain (DPNP)
- Fibromyalgia
- Chronic Musculoskeletal Pain
Pharmacology
- Selective serotonin and norepinephrine reuptake inhibitor (SSNRI)
- Less potent inhibitor of dopamine reuptake
- Well absorbed orally
- Mainly metabolized through hepatic metabolism
Dosage & Administration
- Starting Dose: 30-60 mg/day
- Target Dose: 60 mg/day
- Maximum Dose: 120 mg/day
- Gradual dose reduction recommended
Interaction
- Metabolized by CYP1A2 and CYP2D6 isozymes
- Inhibited by fluvoxamine, cimetidine, quinolone antimicrobials, and potent CYP2D6 inhibitors
Contraindications
- Hypersensitivity to the drug or any inactive ingredients
- Bipolar depression
- Substantial alcohol use or evidence of chronic liver disease
- Controlled narrow-angle glaucoma
Side Effects
- Nausea
- Dizziness
- Dry mouth
- Constipation
- Fatigue
- Increased sweating
- Hyperhidrosis
- Asthenia
- Slightly increased blood pressure
Pregnancy & Lactation
- Pregnancy Category C
- Use during pregnancy only if benefits outweigh risks
- Effect on labor and delivery unknown
- Not recommended during lactation
Precautions & Warnings
- Monitoring for clinical worsening and suicidality
- Blood pressure should be measured regularly
- Caution in concomitant use with NSAIDs, aspirin, or coagulation-affecting drugs
- Use with care in patients with a history of mania or seizure disorder
Use in Special Populations
- Safety and efficacy in pediatric patients not established
Overdose Effects
- No specific antidote
- General measures for managing drug overdose
- Monitoring of vital signs and cardiac rhythm
Therapeutic Class
- Serotonin-norepinephrine reuptake inhibitor (SNRI)
Storage Conditions
- Do not store above 30°C
- Keep away from light and out of the reach of children
Related Brands
- Xinolax DR 60 mg (Capsule (Delayed Release)) - opsonin-pharma-ltd
- Xinolax DR 30 mg (Capsule (Delayed Release)) - opsonin-pharma-ltd
- Xinolax DR 20 mg (Capsule (Delayed Release)) - opsonin-pharma-ltd
- Stresin 20 mg (Capsule (Delayed Release)) - unimed-unihealth-pharmaceuticals-ltd
- Duzela 20 mg (Capsule (Delayed Release)) - sun-pharmaceutical-bangladesh-ltd